$1.85
0.04[2.21%]
At close: Apr 26
$1.85
0[0.00%]
After Hours: 4:30PM EDT
eFFECTOR Therapeutics
(NASDAQ:EFTR)eFFECTOR Therapeutics Stock (NASDAQ:EFTR), Quotes and News Summary
eFFECTOR Therapeutics Stock (NASDAQ: EFTR) stock price, news, charts, stock research, profile.
| Open | $1.810 |
| Close | $1.890 |
| Volume / Avg. | 162.186K / 377.592K |
| Day Range | 1.810 - 1.960 |
| 52 Wk Range | 1.600 - 37.000 |
| Market Cap | $6.822M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 28 |
| Short Interest | 9.44% |
| Days to Cover | 1.7 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About eFFECTOR Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
eFFECTOR Therapeutics Inc is a clinical-stage biopharmaceutical company focused on pioneering the de...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy eFFECTOR Therapeutics (EFTR) stock?
You can purchase shares of eFFECTOR Therapeutics (NASDAQ: EFTR) through any online brokerage.
Who are eFFECTOR Therapeutics's (EFTR) competitors?
Other companies in eFFECTOR Therapeutics’s space includes: Longeveron (NASDAQ:LGVN), Trevena (NASDAQ:TRVN), AquaBounty Techs (NASDAQ:AQB), Kineta (NASDAQ:KA) and Protagenic Therapeutics (NASDAQ:PTIX).
What is the target price for eFFECTOR Therapeutics (EFTR) stock?
The latest price target for eFFECTOR Therapeutics (NASDAQ: EFTR) was reported by HC Wainwright & Co. on Thursday, March 28, 2024. The analyst firm set a price target for 24.00 expecting EFTR to rise to within 12 months (a possible 1197.30% upside). 6 analyst firms have reported ratings in the last year.
Current Stock Price for eFFECTOR Therapeutics (EFTR)?
The stock price for eFFECTOR Therapeutics (NASDAQ: EFTR) is $1.85 last updated April 26, 2024 at 4:30 PM EDT.
Does eFFECTOR Therapeutics (EFTR) pay a dividend?
There are no upcoming dividends for eFFECTOR Therapeutics.
When is eFFECTOR Therapeutics (NASDAQ:EFTR) reporting earnings?
eFFECTOR Therapeutics’s Q1 earnings are confirmed for Tuesday, May 7, 2024.
Is eFFECTOR Therapeutics (EFTR) going to split?
There is no upcoming split for eFFECTOR Therapeutics.
What sector and industry does eFFECTOR Therapeutics (EFTR) operate in?
eFFECTOR Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.